Docteur Guillaume RESIMONT SRL
Docteur Guillaume RESIMONT reported total assets of 261,579 € at the end of the 2025 financial year (annual accounts filed with the NBB on 19 May 2026).
The score of Docteur Guillaume RESIMONT shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +149 % Total assets +73 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Docteur Guillaume RESIMONT's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 19 May 2026
- Year ended 31 Dec 2024filed on 31 Jul 2025
- Year ended 31 Dec 2023filed on 31 Jul 2024
Docteur Guillaume RESIMONT's financial analysis
- Solvency73.2%sector median: 65.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Docteur Guillaume RESIMONT
Docteur Guillaume RESIMONT's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0790.987.686
- VAT number
- BE0790987686
- Peppol
- Registered · 0208:0790987686 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Sep 2022
- Registered office
- 4130 Esneux
- Latest accounts
- 2025 · filed on 19 May 2026
- Activity
- Medical specialists activities (NACE 86220)
Docteur Guillaume RESIMONT (SRL) has been based in Esneux since 2022, active in: medical specialists activities. For 2025, it reports a net profit of 78,229 € and equity of 191,549 €; its revenue is not published. Its solvency stands at 73.2%, above the median of its sector (65.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Docteur Guillaume RESIMONT
Companies in the same business, of comparable size and area, outside its group.
- Smart Skin Solutions Other education n.e.c. Uccle · balance sheet 233,669 €
- Tiny Castermans Pneumologie Other education n.e.c. Diepenbeek · balance sheet 202,511 €
- Societe Medicale Monami Catherine Medical specialists activities Oupeye · balance sheet 415,654 €
- Cabinet Medical d'Oncologie DR Sinapi Isabelle Medical specialists activities Mons · balance sheet 249,034 €
- PFP Society for Medical Oncology Medical specialists activities Momignies · balance sheet 236,580 €
- Physiomega Medical specialists activities Mettet · balance sheet 289,914 €
- Dokter Greet Pauwels Medical specialists activities Bruges · balance sheet 301,381 €
- Spoed Bruneel Medical specialists activities Ghent · balance sheet 304,626 €
Frequently asked questions about Docteur Guillaume RESIMONT
What is the revenue of Docteur Guillaume RESIMONT?
Docteur Guillaume RESIMONT files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Docteur Guillaume RESIMONT?
In Belgium, the VAT number is the company number prefixed with BE: BE0790987686 for Docteur Guillaume RESIMONT, if the company is VAT-registered. Its company number (CBE) is 0790.987.686.
Where is the registered office of Docteur Guillaume RESIMONT?
According to the CBE register, the registered office of Docteur Guillaume RESIMONT is in 4130 Esneux.
What is the equity of Docteur Guillaume RESIMONT?
At the close of the 2025 financial year, the equity of Docteur Guillaume RESIMONT amounts to 191,549 €, a solvency of 73.2% of total assets.
Who manages Docteur Guillaume RESIMONT?
The register lists 1 active mandates at Docteur Guillaume RESIMONT. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Docteur Guillaume RESIMONT
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →